TERN
Terns Pharmaceuticals, Inc. · Healthcare
Orbimed Advisors LLC sold $562K of Terns Pharmaceuticals, Inc.
Director and 10% owner
Sold$561,640
$10.00Price
56,164Shares
−7%Stake
What TERN did after the filing
- The stock from Thu, Jul 18 open, $9.55
- −19.6%
- S&P 500, same days
- 0.0%
Measured over 30 trading days, to the Aug 29 close.
Traded Mon, Jul 15. Filed Wed, Jul 17, 8:48 PM ET, after the close. Returns use the Jul 18 open and the Aug 29 close. Not investment advice.